For example, in vitro and in situ studies suggested that blocking migration of C6 glioma cells by directly targeting myosin II with blebbistatin was very effective even in the presence of several effective signaling pathways such as EGF and PDGF [76]. This evidence concerns the gene EGF and central nervous system cancer.